Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-717-7 | CAS number: 12027-06-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed publication
Data source
Reference
- Reference Type:
- publication
- Title:
- Repeated dose oral toxicity study of the test chemical
- Author:
- Pitsiavas et al
- Year:
- 1 997
- Bibliographic source:
- European Journal of Endocrinology
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Refer below principle
- Principles of method if other than guideline:
- 15 weeks repeated dose oral toxicity study was performed to determine the toxic nature of the test chemical
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Sodium iodide
- EC Number:
- 231-679-3
- EC Name:
- Sodium iodide
- Cas Number:
- 7681-82-5
- Molecular formula:
- INa
- IUPAC Name:
- sodium iodide
- Details on test material:
- - Name of test material: Sodium iodide
- Molecular formula :I Na
- Molecular weight : 149.89427 g/mol
- Substance type:Inorganic
- Physical state:Solid
- Impurities (identity and concentrations):N/A
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on species / strain selection:
- No data
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: No data
- Age at study initiation: 4 weeks
- Weight at study initiation: No data
- Fasting period before study: No data
- Housing: No data
- Diet (e.g. ad libitum): Rat chow
- Water (e.g. ad libitum): No data
- Acclimation period: No data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data
- Humidity (%):No data
- Air changes (per hr): No data
- Photoperiod (hrs dark / hrs light): No data
IN-LIFE DATES: From: To: No data
Administration / exposure
- Route of administration:
- oral: drinking water
- Details on route of administration:
- No data
- Vehicle:
- water
- Remarks:
- Sterile drinking water
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS: The test chemical at dose level of 0 or 10mg/Kg bw was dissolved in sterile distilled water to produce iodide water
DIET PREPARATION
- Rate of preparation of diet (frequency): No data
- Mixing appropriate amounts with (Type of food): No data
- Storage temperature of food: No data
VEHICLE
- Justification for use and choice of vehicle (if other than water): Sterile drinking water
- Concentration in vehicle: 0 or 10 mg/Kg/day
- Amount of vehicle (if gavage): No data
- Lot/batch no. (if required): No data
- Purity: No data - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- No data
- Duration of treatment / exposure:
- 15 weeks
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- 0 or 10 mg/Kg/bw
- No. of animals per sex per dose:
- Total: 17
0 mg/Kg/bw: 8
10 mg/Kg/bw: 9 - Control animals:
- yes, concurrent vehicle
- Details on study design:
- No data
- Positive control:
- No data
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: No data
- Time schedule: No data
- Cage side observations checked in table [No.?] were included. No data
DETAILED CLINICAL OBSERVATIONS: No data
- Time schedule: No data
BODY WEIGHT: No data
- Time schedule for examinations: No data
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
- Time schedule for examinations: No data
OPHTHALMOSCOPIC EXAMINATION: No data
- Time schedule for examinations: No data
- Dose groups that were examined: No data
HAEMATOLOGY: No data
- Time schedule for collection of blood: No data
- Anaesthetic used for blood collection: No data
- Animals fasted: No data
- How many animals: No data
- Parameters checked in table [No.?] were examined. No data
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: No data
- Animals fasted: No data
- How many animals: No data
- Parameters checked in table [No.?] were examined. Total thyroxine (T4) and total tri-iodothyronine (T3) were analysed, Thyrotrophin (TSH), Reverse T3
URINALYSIS: No data
- Time schedule for collection of urine: No data
- Metabolism cages used for collection of urine: No data
- Animals fasted: No data
- Parameters checked in table [No.?] were examined. No data
NEUROBEHAVIOURAL EXAMINATION: No data
- Time schedule for examinations: No data
- Dose groups that were examined: No data
- Battery of functions tested: sensory activity / grip strength / motor activity / other: No data
OTHER: No data - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes, thyoid gland was examined
HISTOPATHOLOGY: Yes, After washing out red blood cells, the
thyroid gland was removed and stored in Karnovsky fixative (2.5% glutaraldehyde, 2.5% pure formalin in 0.1M MOPS buffer, pH7.4) for 3 h and then cut into
1mm3 blocks. Both lobes were diced and processed using a Polaron E9000 EM Tissue Processor. On average 20 diced sections were prepared from each rat thyroid gland and 6 were selected randomly for block preparation. For histological assessment sections were cut at 0.5 mm thickness and stained with methylene blue; they were photographed using Kodak Technical Pan
Film (black and white; magnification X 399). For EM assessment resin-embedded ultra-thin sections were stained with uranyl acetate and lead citrate and examined using a Phillips EM 201S transmission electron microscope. Photographs of sections were recorded on Kodak SO-281 electron microscope film (35mm) and developed in Kodak D19 developer. The observed changes were graded by two of the authors (VP and LM) independently without knowledge of the treatment groups. The changes were graded as follows: (a) follicular disruption, ER dilatation and lymphocytic infiltration: 0, none observed; 1, low; 2, moderate; 3, marked; (b) lysosomal numbers: 1, low; 2, moderate; 3, marked; (c) lipofuscinogenesis: 1, low;
2, moderate; 3, marked. - Other examinations:
- No data
- Statistics:
- The thyroid function results are expressed as means±S.E. Analysis of difference was performed using analysis of variance (ANOVA) followed by Scheffes test for significance of differences among multiple experimental groups.
Results and discussion
Results of examinations
- Clinical signs:
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- not specified
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- Iodide had no effect on reverse T3
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- Macroscopically the thyroid gland appeared small and white in colour.
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- In the 15-week-old Wistar rat controls fed sterile water, the thyroid follicles were morphologically intact, microvilli were regular in shape at the apical surface and the colloid was evenly stained. Nuclei were regular in shape with evenly stained chromatin and regular nucleoli. Under higher magnification the ER was of normal appearance and mitochondria also appeared normal with oval and rod shapes present. Lysosomes were present with low numbers of lipofuscin bodies. There was no evidence of tissue damage, apoptosis or inclusion bodies.
The Wistar rats on iodide water gave similar results to the Wistar controls. Under EM examination the follicles appeared intact with cuboidal cells. The colloid was evenly stained with regular microvilli at the apical surface. Nuclei were regularly shaped with evenly stained chromatin. Both ER and mitochondria appeared normal. Lysosomes were present in greater numbers than in the control groups. Tissue damage and apoptosis were not observed in this group, nor were inclusion bodies.
Folicular architecture in the Iodide treated groups was essentially normal. Lysosomes were increased and there was no lymphocytic infiltration. - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
- Details on results:
- No data
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 10 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- other: No significant effects were noted at the mentioned dose level
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Table 1 Thyroid function test results and weights of 15-week-old W rats on sterile water, iodide water. Results are reported as mean±S.E. with n indicating the number in each group.
|
Control group |
Test group |
Total T4 |
663.3 2.3 |
62.1 4.0 |
Total T3 |
1.04 0.08 |
0.84 0.04 |
Reverse T3 |
0.090 0.018 |
0.057 0.02 |
TSH |
0.729 0.2 |
5.76 0.76* |
Weight (g) |
331 32 |
365 39 |
*P < 0:05 compared with control groups
Table 2 Results of thyroid ultrastructural changes in 15-week-old W rats treated with sterile water (Control) and iodide water.
|
Control |
Test group |
Macroscopic gland appearance |
Small, white colour |
Small, white colour |
Follicles |
Morphologically intact |
Morphologically intact |
Follicular disruption |
0 |
0 |
Colloid |
Evenly stained |
Evenly stained |
Microvilli |
Regular |
Regular |
Nucleus |
Regular shape, evenly stained |
Regular shape, evenly stained |
Apoptosis |
None observed |
None observed |
ER dialation |
0 |
0 |
Lysosomal numbers |
1 |
3 |
Lipofuscinogenesis |
1 |
2 |
Inclusion bodies |
0 |
0 |
Lymphocytic infiltration |
0 |
1 |
Results were graded as follows: follicular disruption, ER dilatation, lymphocytic infiltration: 0 – none observed, 1 – low, 2 – moderate, 3 – marked; lysomomal numbers: 1 – low, 2 – moderate, 3 – marked; lipofuscinogenesis: 1 – low, 2 – moderate, 3 – marked.
Applicant's summary and conclusion
- Conclusions:
- The No Observed Adverse Effect Level (NOAEL) for the test chemical using Wistar rats for 15 weeks repeated oral toxicity study is considered to be 10 mg/Kg bw.
- Executive summary:
15 weeks repeated dose oral toxicity study was performed to determine the toxic nature of the test chemical. The study was performed using 8-10/group Wistar rats for 15 weeks. The test chemical at dose level of 0 or 10 mg/Kg bw was dissolved in sterile distilled water to produce iodide water. Blood was collected for thyroid function analysis prior to removal of the thyroid. The thyroid gland was further removed for microscopic examination.Iodide had no effect on reverse T3. Macroscopically the thyroid gland appeared small and white in colour. The Wistar rats on iodide water gave similar results to the Wistar controls. Under EM examination the follicles appeared intact with cuboidal cells. The colloid was evenly stained with regular microvilli at the apical surface. Nuclei were regularly shaped with evenly stained chromatin. Both ER and mitochondria appeared normal. Lysosomes were present in greater numbers than in the control groups. Tissue damage and apoptosis were not observed in this group, nor were inclusion bodies. Follicular architecture in the Iodide treated groups was essentially normal. Lysosomes were increased and there was no lymphocytic infiltration. Based on the observations made, No Observed Adverse Effect Level (NOAEL) for the test chemical using Wistar rats for 15 weeks repeated oral toxicity study is considered to be 10 mg/Kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.